(Q28084150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Francesco Violi

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

Francesco Baratta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

Maria Del Ben

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

Licia Polimeni

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

8

Francesco Angelico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Ludovica Perri

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Fabiana Albanese

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

1 reference

1 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Hepatology

16 February 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

10

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

1325-1336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

Antioxidants, inflammation and cardiovascular disease

16 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Vitamin E and nonalcoholic fatty liver disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Atherosclerosis — An Inflammatory Disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

20 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

20 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Therapeutic potential of resveratrol: the in vivo evidence

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Long-term follow-up of patients with NAFLD and elevated liver enzymes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Nonalcoholic fatty liver disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Moderate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Relationship between platelet and urinary 8-Iso-PGF2α levels in subjects with different degrees of NOX2 regulation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Silymarin in non alcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Endothelial dysfunction as a cellular mechanism for vascular failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

29 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

29 September 2017

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Silybin and the liver: from basic research to clinical practice.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

F2-isoprostanes as an indicator and risk factor for coronary heart disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Is oxidative stress a therapeutic target in cardiovascular disease?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Measurement of endothelial function and its clinical utility for cardiovascular risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Resveratrol inhibits nonalcoholic fatty liver disease in rats

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

The isoprostanes: unique products of arachidonic acid oxidation-a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Pathogenesis of steatohepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Biological effects of resveratrol

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Body fat topography as an independent predictor of fatty liver

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

The morphology and metabolism of intraabdominal adipose tissue in men

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease

2 June 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Nonalcoholic fatty liver disease and carotid atherosclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Oxidative stress parameters in paediatric non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Antioxidant and antiradical activities of L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Platelet NOX, a novel target for anti-thrombotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V7.I10.1325

Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

The questionable association of vitamin E supplementation and mortality--inconsistent results of different meta-analytic approaches.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Silibinin protects mice from T cell-dependent liver injury

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4450196

Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

27 November 2018

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

12 December 2020

Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease

1 reference

12 December 2020

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

1 reference

12 December 2020

Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial

1 reference

12 December 2020

Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study

1 reference

12 December 2020

Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients

1 reference

12 December 2020

The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis

1 reference

12 December 2020

Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients

1 reference

12 December 2020

Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis

1 reference

12 December 2020

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

1 reference

12 December 2020

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

12 December 2020

Levels of the oxidative stress marker γ-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease

1 reference

12 December 2020

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

1 reference

12 December 2020

Antioxidant activity of silybin in vivo during long-term iron overload in rats

1 reference

12 December 2020

Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V7.I10.1325

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26052378%20AND%20SRC:MED&resulttype=core&format=json